My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format

Send to:

Choose Destination

    N Engl J Med. 2008 Sep 25;359(13):1410.

    Retraction: Barlogie et al. Duration of survival in patients with myeloma treated with thalidomide. N Engl J Med 2008;359:210-2.

    Barlogie B, Shaughnessy JD Jr, Crowley J.

    Retraction of:

    PMID: 18815407 [PubMed - indexed for MEDLINE]

    Publication Types

    Publication Types:

    LinkOut - more resources

    Full Text Sources:

    Other Literature Sources:

    Libraries:

    Supplemental Content

    Click here to read

    Related articles

    Patient drug information

    • Thalidomide (Thalomid®)

      Thalidomide is used along with dexamethasone to treat multiple myeloma in people who have been recently found to have this disease. It is also used alone or with other medications to treat and prevent skin symptoms of er...

    • Source: AHFS Consumer Medication Information

    Recent activity